212 related articles for article (PubMed ID: 33672903)
41. Photocatalytic Protein Damage by Silver Nanoparticles Circumvents Bacterial Stress Response and Multidrug Resistance.
Shi T; Wei Q; Wang Z; Zhang G; Sun X; He QY
mSphere; 2019 May; 4(3):. PubMed ID: 31043515
[TBL] [Abstract][Full Text] [Related]
42. Development and validation of a triplex quantitative real-time PCR assay to detect efflux pump-mediated antibiotic resistance in Burkholderia pseudomallei.
Webb JR; Price EP; Somprasong N; Schweizer HP; Baird RW; Currie BJ; Sarovich DS
Future Microbiol; 2018 Sep; 13(12):1403-1418. PubMed ID: 30256166
[TBL] [Abstract][Full Text] [Related]
43. Biologically rapid synthesis of silver nanoparticles by
Akter S; Huq MA
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):672-682. PubMed ID: 32075448
[TBL] [Abstract][Full Text] [Related]
44. Burkholderia pseudomallei acquired ceftazidime resistance due to gene duplication and amplification.
Chirakul S; Somprasong N; Norris MH; Wuthiekanun V; Chantratita N; Tuanyok A; Schweizer HP
Int J Antimicrob Agents; 2019 May; 53(5):582-588. PubMed ID: 30639528
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of bla(PenA) and bla(OXA) in Burkholderia pseudomallei Isolated from Patients at Sappasitthiprasong Hospital and Their Susceptibility to Ceftazidime and Carbapenems.
Panya M; Thirat S; Wanram S; Panomket P; Nilsakul J
J Med Assoc Thai; 2016 Jan; 99 Suppl 1():S12-6. PubMed ID: 26817233
[TBL] [Abstract][Full Text] [Related]
46. Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei.
Chantratita N; Rholl DA; Sim B; Wuthiekanun V; Limmathurotsakul D; Amornchai P; Thanwisai A; Chua HH; Ooi WF; Holden MT; Day NP; Tan P; Schweizer HP; Peacock SJ
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17165-70. PubMed ID: 21969582
[TBL] [Abstract][Full Text] [Related]
47. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis.
Jenney AW; Lum G; Fisher DA; Currie BJ
Int J Antimicrob Agents; 2001 Feb; 17(2):109-13. PubMed ID: 11165114
[TBL] [Abstract][Full Text] [Related]
48. Tannic acid-mediated green synthesis of antibacterial silver nanoparticles.
Kim TY; Cha SH; Cho S; Park Y
Arch Pharm Res; 2016 Apr; 39(4):465-473. PubMed ID: 26895244
[TBL] [Abstract][Full Text] [Related]
49. Molecular epidemiology and antibiotic resistance of Burkholderia pseudomallei isolates from Hainan, China: A STROBE compliant observational study.
Rao C; Hu Z; Chen J; Tang M; Chen H; Lu X; Cao L; Deng L; Mao X; Li Q
Medicine (Baltimore); 2019 Mar; 98(9):e14461. PubMed ID: 30817562
[TBL] [Abstract][Full Text] [Related]
50. Epetraborole, a leucyl-tRNA synthetase inhibitor, demonstrates murine efficacy, enhancing the in vivo activity of ceftazidime against Burkholderia pseudomallei, the causative agent of melioidosis.
Cummings JE; Lunde CS; Alley MRK; Slayden RA
PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011795. PubMed ID: 38011278
[TBL] [Abstract][Full Text] [Related]
51. Microbial glycolipoprotein-capped silver nanoparticles as emerging antibacterial agents against cholera.
Gahlawat G; Shikha S; Chaddha BS; Chaudhuri SR; Mayilraj S; Choudhury AR
Microb Cell Fact; 2016 Feb; 15():25. PubMed ID: 26829922
[TBL] [Abstract][Full Text] [Related]
52. Synthesis, optimization, and characterization of silver nanoparticles from Acinetobacter calcoaceticus and their enhanced antibacterial activity when combined with antibiotics.
Singh R; Wagh P; Wadhwani S; Gaidhani S; Kumbhar A; Bellare J; Chopade BA
Int J Nanomedicine; 2013; 8():4277-90. PubMed ID: 24235826
[TBL] [Abstract][Full Text] [Related]
53. Diffusion and activity of antibiotics against Burkholderia pseudomallei biofilms.
Pibalpakdee P; Wongratanacheewin S; Taweechaisupapong S; Niumsup PR
Int J Antimicrob Agents; 2012 Apr; 39(4):356-9. PubMed ID: 22364716
[TBL] [Abstract][Full Text] [Related]
54. Highly resistant Burkholderia pseudomallei small colony variants isolated in vitro and in experimental melioidosis.
Häussler S; Rohde M; Steinmetz I
Med Microbiol Immunol; 1999 Nov; 188(2):91-7. PubMed ID: 10753061
[TBL] [Abstract][Full Text] [Related]
55. Tannic acid-modified silver nanoparticles for enhancing anti-biofilm activities and modulating biofilm formation.
Liu L; Ge C; Zhang Y; Ma W; Su X; Chen L; Li S; Wang L; Mu X; Xu Y
Biomater Sci; 2020 Sep; 8(17):4852-4860. PubMed ID: 32734981
[TBL] [Abstract][Full Text] [Related]
56. Rapid antimicrobial susceptibility testing and β-lactam-induced cell morphology changes of Gram-negative biological threat pathogens by optical screening.
McLaughlin HP; Sue D
BMC Microbiol; 2018 Dec; 18(1):218. PubMed ID: 30563467
[TBL] [Abstract][Full Text] [Related]
57. Antibiofilm and antivirulence potential of silver nanoparticles against multidrug-resistant Acinetobacter baumannii.
Hetta HF; Al-Kadmy IMS; Khazaal SS; Abbas S; Suhail A; El-Mokhtar MA; Ellah NHA; Ahmed EA; Abd-Ellatief RB; El-Masry EA; Batiha GE; Elkady AA; Mohamed NA; Algammal AM
Sci Rep; 2021 May; 11(1):10751. PubMed ID: 34031472
[TBL] [Abstract][Full Text] [Related]
58. Application of a marine luminescent Vibrio sp. B4L for biosynthesis of silver nanoparticles with unique characteristics, biochemical properties, antibacterial and antibiofilm activities.
Zamanpour N; Mohammad Esmaeily A; Mashreghi M; Shahnavaz B; Reza Sharifmoghadam M; Kompany A
Bioorg Chem; 2021 Sep; 114():105102. PubMed ID: 34174634
[TBL] [Abstract][Full Text] [Related]
59. Antibacterial, antibiofilm, and antiquorum sensing activities of phytosynthesized silver nanoparticles fabricated from Mespilus germanica extract against multidrug resistance of Klebsiella pneumoniae clinical strains.
Foroohimanjili F; Mirzaie A; Hamdi SMM; Noorbazargan H; Hedayati Ch M; Dolatabadi A; Rezaie H; Bishak FM
J Basic Microbiol; 2020 Mar; 60(3):216-230. PubMed ID: 31994223
[TBL] [Abstract][Full Text] [Related]
60. Green Synthesis of Silver Nanoparticles Using
Huq MA
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
